Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent Cervical Adenocarcinomas
NCT02868892Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in cervical adenocarcinoma, cervical adenosquamous carcinoma (ASC), sponsored by Western Regional Medical Center. Started Jul 2015; status: terminated.
02
Drugs
pemetrexed
03
Conditions
cervical adenocarcinomacervical adenosquamous carcinoma (ASC)
Beyond the preview
Go deeper on NCT02868892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868892.